James analyst James Rollyson updated his outlook on USA Compression Partners LP (NYSE:USAC), raising the firm's price target on the stock to $30.00, up from the previous $27.00, while reiterating an Outperform rating.

As previously reported, Raymond James downgraded Third Harmonic Bio (THRD) to Market Perform from Outperform and removed the firm’s prior $18

Raymond James lowered the firm’s price target on Haemonetics (HAE) to $115 from $120 and keeps a Strong Buy rating on the shares. Shares sold

James analyst made adjustments to the financial outlook for Fidelity National Information Services (NYSE:FIS), reducing the price target to $78.00 from the previous $101.00. Despite the cut in the price target,